VERICEL CORPORATION (VCEL) ROI
- 2014-09-30: ROI -53.95%.
- 2013-03-31: ROI 69.95%.
- 2012-12-31: ROI 91.93%.
- 2012-09-30: ROI 104.16%.
Complete source-backed roi history.
- Available history
- 2011-09-30 to 2014-09-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2014-09-30 | -53.95% |
| 2013-03-31 | 69.95% |
| 2012-12-31 | 91.93% |
| 2012-09-30 | 104.16% |
| 2012-06-30 | 104.17% |
| 2012-03-31 | 111.45% |
| 2011-12-31 | 152.57% |
| 2011-09-30 | 186.71% |
Annual ROI
| Date | ROI |
|---|---|
| 2012-12-31 | 91.93% |
| 2011-12-31 | 152.57% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |